✦ LIBER ✦
Daclizumab was efficacious and safe in preventing acute rejection in non-sensitized patients receiving first cardiac transplants
✍ Scribed by Michael S. Lauer
- Book ID
- 117836328
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 71 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1361-2611
No coin nor oath required. For personal study only.